Gabriel Olmedilla
La Paz, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy.
Journal: EJHaem
Published: January 20, 2022
Metastatic Malignant Peritoneal Mesothelioma Mimicking an Autoinflammatory Syndrome in a 12-Year-Old Boy.
Journal: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
Published: April 19, 2021
Two independent consecutive lymphoma cases carry an identical MYD88 mutation but differ in their IGVH rearrangement.
Journal: British journal of haematology
Published: June 25, 2020
Homeostasis: apoptosis and cell cycle in normal and pathological prostate.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: May 08, 2018
PI3K pathway and Bcl-2 family. Clinicopathological features in prostate cancer.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: January 11, 2018
Expression of several cytokines in prostate cancer: Correlation with clinical variables of patients. Relationship with biochemical progression of the malignance.
Journal: Cytokine
Published: October 05, 2015
Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer.
Journal: Cytokine
Published: March 15, 2013
Two-weekly dose-adjusted (DA)-EPOCH-like chemotherapy with high-dose dexamethasone plus rituximab (DA-EDOCH14-R) in poor-prognostic untreated diffuse large B-cell lymphoma.
Journal: British journal of haematology
Published: July 03, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026